why choose us

First received: June 02, 2023

Clinical Trial: A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: IBS - Irritable Bowel Syndrome

Study Type: INTERVENTIONAL


Official Title: A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients: A Two-Center, Randomized, Double-Blind, Placebo-controlled Study

Brief Summary: The goal of this interventional clinical study is to study whether the consumption of QiMeiYan Probiotics in 25-35 young people with Mild irritable bowel syndrome (IBS Score 75 - 175) will reduce the frequency of Diarrhea.140 eligible participants (70 males and 70 females) will be enrolled in two study sites and randomly assigned to two groups of products QiMeiYan Probiotics and placebo.All participants will consume assigned products once a day after meals and record the critical data such as photo of feces.Three…

Read more